{ "items" : [
    { "id" : "http://dbpedia.org/resource/Nicholas_Lydon"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "Nicholas Lydon",
          "Lydon, Nicholas" ] ,
        "http://xmlns.com/foaf/0.1/depiction" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Nicholas_Lydon.jpg" ] ,
        "http://purl.org/dc/elements/1.1/description" : [ "British biochemist" ] ,
        "http://dbpedia.org/ontology/almaMater" : [ "http://dbpedia.org/resource/University_of_Leeds",
          "http://dbpedia.org/resource/University_of_Dundee" ] ,
        "http://dbpedia.org/ontology/award" : [ "http://dbpedia.org/resource/Lasker_Award",
          "http://dbpedia.org/resource/Royal_Society",
          "http://dbpedia.org/resource/Japan_Prize" ] ,
        "http://dbpedia.org/ontology/birthDate" : [ "1957-02-27Z" ] ,
        "http://dbpedia.org/ontology/birthYear" : [ "1957Z" ] ,
        "http://dbpedia.org/ontology/knownFor" : [ "http://dbpedia.org/resource/Imatinib" ] ,
        "http://dbpedia.org/ontology/thumbnail" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Nicholas_Lydon.jpg?width=300"] } } }
